Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assay method for single-chain urokinase-type plasminogen activator.

O Matsuo1, S Ueshima, K Okada

  • 1Department of Physiology, Kinki University School of Medicine, Osakasayama, Japan.

Hematologic Pathology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

INVESTIGATION OF A PRACTICAL PATIENT DOSE INDEX FOR ASSESSMENT OF PATIENT ORGAN DOSE FROM CONE-BEAM COMPUTED TOMOGRAPHY IN RADIATION THERAPY USING A MONTE CARLO SIMULATION.

Radiation protection dosimetry·2018
Same author

SU-E-J-26: Automated Estimation Method of Patient Setup Errors Using Simulated Portal Images for Prostate Cancer Radiotherapy.

Medical physics·2017
Same author

SU-E-I-92: Accuracy Evaluation of Depth Data in Microsoft Kinect.

Medical physics·2017
Same author

SU-E-I-91: Development of a Compact Radiographic Simulator Using Microsoft Kinect.

Medical physics·2017
Same author

TU-E-BRB-01: Similar-Case-Based Optimization of Beam Arrangements in Stereotactic Body Radiation Therapy.

Medical physics·2017
Same author

WE-G-BRCD-04: Development of Automated Determination Method of Robust Beam Directions against Patient Setup Errors Based on Spatial Distribution of Electron Density in Particle Therapy.

Medical physics·2017

A novel calorimetric assay quantifies single-chain urokinase-type plasminogen activator (scu-PA) activity. This method defines one unit of scu-PA based on p-nitroaniline release, establishing its equivalence to 335 two-chain u-PA units.

Area of Science:

  • Biochemistry
  • Enzymology
  • Assay Development

Background:

  • Single-chain urokinase-type plasminogen activator (scu-PA) is a precursor protein derived from human kidney cell cultures.
  • Urokinase-type plasminogen activator (u-PA) is a serine enzyme crucial for activating plasminogen to plasmin.
  • Understanding scu-PA activity is vital for research in fibrinolysis and related biological processes.

Purpose of the Study:

  • To develop and describe a new quantitative calorimetric assay method for measuring scu-PA activity.
  • To establish a standardized unit definition for scu-PA based on enzymatic activity.
  • To determine the relationship between scu-PA activity and the activity of its two-chain form (u-PA).

Main Methods:

  • A quantitative calorimetric assay was employed to measure scu-PA activity.

Related Experiment Videos

  • scu-PA was activated by plasmin to form two-chain u-PA (tcu-PA).
  • The release of p-nitroaniline from the substrate pyro-Glu-Gly-Arg-pNA by tcu-PA was monitored spectrophotometrically at 405 nm.

    • Main Results:

    • A precise unit definition for scu-PA was established: one unit corresponds to 1 nmol of p-nitroaniline released per second.
    • The study found that one unit of scu-PA is equivalent to 335 international units (IU) of two-chain u-PA.
    • The calorimetric method demonstrated sensitivity and specificity for quantifying scu-PA enzymatic activity.

    Conclusions:

    • The developed calorimetric assay provides a reliable method for quantifying scu-PA activity.
    • The established unit definition and conversion factor facilitate consistent measurement and comparison of scu-PA levels.
    • This assay advances the study of plasminogen activation pathways and their clinical relevance.